BEAM – beam therapeutics inc. (US:NYSE)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

BEAM

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/20

08:02 am

beam

Beam Therapeutics (NASDAQ:BEAM) was given a new $74.00 price target on by analysts at Canaccord Genuity Group Inc..

Low Report

Beam Therapeutics (NASDAQ:BEAM) was given a new $74.00 price target on by analysts at Canaccord Genuity Group Inc..

Report

2/18

07:46 pm

beam

Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory [Yahoo! Finance]

Low Report

Analyst Bullish on Beam Therapeutics (BEAM) Over Drug Program Trajectory [Yahoo! Finance]

Report

2/15

07:12 pm

beam

Why Beam Therapeutics (BEAM) Is Up 5.3% After New Gene-Editing IP Deal And FDA Fast Track [Yahoo! Finance]

Low Report

Why Beam Therapeutics (BEAM) Is Up 5.3% After New Gene-Editing IP Deal And FDA Fast Track [Yahoo! Finance]

Report

2/15

08:53 am

beam

H.C. Wainwright Reiterated Buy on Beam Therapeutics (BEAM) After BEAM-302 FDA Expedited Approval [Yahoo! Finance]

Low Report

H.C. Wainwright Reiterated Buy on Beam Therapeutics (BEAM) After BEAM-302 FDA Expedited Approval [Yahoo! Finance]

Report

2/8

02:04 am

beam

Beam Therapeutics (NASDAQ:BEAM) was downgraded by analysts at Wall Stree

Medium Report

Beam Therapeutics (NASDAQ:BEAM) was downgraded by analysts at Wall Stree

Report

1/29

07:31 am

beam

Bernstein Maintains an Outperform Rating on Beam Therapeutics Inc. (BEAM) [Yahoo! Finance]

Low Report

Bernstein Maintains an Outperform Rating on Beam Therapeutics Inc. (BEAM) [Yahoo! Finance]

Report

1/22

03:21 pm

beam

Cathie Wood quietly buys $7.27 million of popular tech stock [Yahoo! Finance]

Low Report

Cathie Wood quietly buys $7.27 million of popular tech stock [Yahoo! Finance]

Report

1/21

10:57 am

beam

Beam Therapeutics (NASDAQ:BEAM) was given a new $41.00 price target on by analysts at Tudor Pickering.

Low Report

Beam Therapeutics (NASDAQ:BEAM) was given a new $41.00 price target on by analysts at Tudor Pickering.

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/4/2025

07:00 am

beam

beam therapeutics inc.

MISS Report

-3.7%

beam therapeutics inc.

Report

8/5/2025

07:00 am

beam

beam therapeutics inc.

BEAT Report

-2.1%

beam therapeutics inc.

Report

5/6/2025

07:00 am

beam

beam therapeutics inc.

MISS Report

-18.6%

beam therapeutics inc.

Report

2/25/2025

07:00 am

beam

beam therapeutics inc.

BEAT Report

-3.3%

beam therapeutics inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

2/20

03:50 pm

Initiates

Buy

Canaccord Genuity

Low

Report

0.3%

Report

2/20

06:51 am

Initiates

BUY

CANACCORD

Medium

Report

-3.2%

Report

2/20

06:29 am

Initiates

BUY

CANACCORD

Low

Report

-2.0%

Report

1/21

10:11 am

Maintains

Outperform

Bernstein

Low

Report

0.4%

Report

1/21

10:11 am

Maintains

Outperform

Bernstein

Low

Report

0.4%

Report

1/20

07:09 pm

Reiterates

Outperform

Sanford C. Bernstein

Low

Report

0.1%

Report

1/9

06:10 am

Upgrades

Hold

UBS Group AG

Medium

Report

-3.0%

Report

1/7

03:16 pm

Initiates

Neutral

UBS

Low

Report

-2.5%

Report

Date

Time

Symbol

Headline

Impact

2/12

04:06 pm

beam

Form 8-K Beam Therapeutics Inc. For: Feb 09

Medium Report

Form 8-K Beam Therapeutics Inc. For: Feb 09

Report

2/9

06:19 am

beam

Form SCHEDULE 13G Beam Therapeutics Inc. Filed by: STATE STREET CORP

Low Report

Form SCHEDULE 13G Beam Therapeutics Inc. Filed by: STATE STREET CORP

Report

2/5

04:06 pm

beam

Form 8-K Beam Therapeutics Inc. For: Jan 31

Medium Report

Form 8-K Beam Therapeutics Inc. For: Jan 31

Report

2/5

02:57 pm

beam

Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.

Low Report

Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.

Report

2/5

01:17 pm

beam

Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: FMR LLC

Low Report

Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: FMR LLC

Report

2/3

11:34 am

beam

Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: ARK Investment Management LLC

Low Report

Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: ARK Investment Management LLC

Report

2/2

04:05 pm

beam

Form 4 Beam Therapeutics Inc. For: Jan 31 Filed by: Bellon Christine

Low Report

Form 4 Beam Therapeutics Inc. For: Jan 31 Filed by: Bellon Christine

Report

2/2

04:05 pm

beam

Form 4 Beam Therapeutics Inc. For: Jan 31 Filed by: Emany Sravan Kumar

Low Report

Form 4 Beam Therapeutics Inc. For: Jan 31 Filed by: Emany Sravan Kumar

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.